Sarepta soars on positive results from early-stage DMD clinical trial

Lloyd Doyle
September 6, 2017

The company has market cap of $2.93 billion. It closed at $32.13 lastly. (RRGB) has risen 52.55% since September 6, 2016 and is uptrending. It has underperformed by 3.46% the S&P500. LGL Partners LLC's holdings in Sarepta Therapeutics were worth $300,000 as of its most recent SEC filing. It is 0.00% or $0 reaching $0.0002 per share. Following the completion of the sale, the director now owns 62,471 shares in the company, valued at $2,561,311. Short traders are more bearish on shares of Sarepta Therapeutics, Inc. of late if you pay attention to the increase in short interest. About 974,679 shares traded.

The stock of Sarepta Therapeutics Inc (NASDAQ:SRPT) is a huge mover today! It has outperformed by 80.12% the S&P500. (NASDAQ:SRPT) now have an ABR of 1.38.which is marked on a basic 1 to 5 scale, where 1 stands for a Strong Buy and 5 represents Strong Sell. Therefore 75% are positive. According to Thomson Reuters, sell-side analysts are predicting a consensus target price of $74.41 on company stock. Jefferies initiated the stock with "Hold" rating in Friday, October 23 report.

Sarepta Therapeutics (NASDAQ:SRPT) last issued its earnings results on Wednesday, July 19th. Morgan Stanley has "Equal-Weight" rating and $33 target. Credit Suisse Group set a $64.00 price objective on Sarepta Therapeutics and gave the stock a "buy" rating in a research report on Tuesday, July 18th. Sarepta Therapeutics now has an average rating of "Buy" and an average target price of $61.28.

Investors sentiment decreased to 1.07 in 2016 Q4. The company's quarterly revenue was up 350000.0% on a year-over-year basis. It dropped, as 42 investors sold SRPT shares while 46 reduced holdings.

These funds have also shifted positions in (SRPT). 68,090 are held by Wells Fargo & Mn. Its shares shot up by 35% this morning. Great West Life Assurance Can owns 4,935 shares or 0% of their U.S. portfolio. Inc. lifted its stake in Sarepta Therapeutics by 772.2% during the second quarter. Citigroup holds 0% or 27,835 shares. California Employees Retirement Systems has 0.01% invested in Sarepta Therapeutics Inc (NASDAQ:SRPT). Blackrock Institutional Tru Na accumulated 0.01% or 1.31 million shares. Investment Counselors Of Maryland Llc, a Maryland-based fund reported 327,265 shares. Rock Springs Capital Management Lp owns 205,000 shares with a value of $6,911,000. Guggenheim Ltd reported 85,769 shares. EVP, CFO & CBO Sandesh Mahatme sold 50,000 shares at an average price of $41.00 on Thursday the 20th. It also increased its holding in Acceleron Pharma (NASDAQ:XLRN) by 30,097 shares in the quarter, for a total of 619,987 shares, and has risen its stake in Quotient (NASDAQ:QTNT).

Among 31 analysts covering Devon Energy Corporation (NYSE:DVN), 20 have Buy rating, 0 Sell and 11 Hold.

A number of equities analysts recently issued reports on the company. As per Friday, January 15, the company rating was downgraded by Piper Jaffray. The stock has "Outperform" rating by RBC Capital Markets on Wednesday, September 28. Eckler asked, adding "one of the bear cases we hear for Sarepta is that the small amount of dystrophin production and lack of a confirmed clinical benefit leave the door open to payor pushback and denials". "The rating was downgraded by SunTrust on Friday, August 7 to ". The firm has "Outperform" rating by RBC Capital Markets given on Thursday, February 18. Stifel Nicolaus maintained the shares of DVN in report on Thursday, July 13 with "Buy" rating. Its up 0.03, from 0.89 in 2016Q3. Glenmede Na stated it has 2,000 shares. Meeder Asset holds 0.47% or 106,768 shares in its portfolio. Tiaa Cref Investment Llc reported 0% stake. Legal General Public Ltd Company, United Kingdom-based fund reported 17,149 shares. Blackrock Advsr Limited Liability has 938,370 shares. The shares were purchased at an average price of $41.00. Maine-based Schroder Grp has invested 0.1% in Devon Energy Corp (NYSE:DVN). Moreover, Thomson Horstmann & Bryant Inc has 1.32% invested in the company for 189,923 shares.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Other reports by Iphone Fresh

Discuss This Article